PACTR201807337809744尚未招募未知
Effect of transjugular intrahepatic portosystemic shunt insertion in hepatic patients on the haemodynamics
ational Liver Institute0 个研究点目标入组 40 人开始时间: 2018年7月30日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 13 Year(s) 至 18 Year(s)（—）
- 性别
- All
入选标准
- •Adult patients scheduled for elective TIPS procedure with stable haemodynamic condition and acceptable echocardiography.
排除标准
- •Cardiac co-morbidity.
- •Severe coagulation disorder.
- •Renal failure.
- •Neoplastic disease.
研究者
相似试验
招募中
不适用
Influence of the transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients on sarcopeniaMuscle wasting and atrophy, not elsewhere classified, multiple sitesM62.59K74.6Other and unspecified cirrhosis of liverDRKS00024507niversitätsklinikum Freiburg100
撤回
不适用
The effects of Transjugular Intrahepatic Portosystemic Shunt placement on von Willebrand factor levels in plasma of patients with cirrhosis and portal hypertension.NL-OMON38711niversitair Medisch Centrum Groningen16
已完成
不适用
The impact of trans-jugular intrahepatic portosystemic shunts on muscle mass in chronic liver disease.portal hypertensionsarcopeniaTrans-jugular intrahepatic portosystemic shuntOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonMusculoskeletal - Other muscular and skeletal disorderscirrhosisACTRN12619000081112Department of Gastroenterology and Hepatology, Austin Health14
已完成
不适用
Covered transjugular intrahepatic portosystemic stent shunt versus optimised medical treatment for the secondary prevention of variceal bleeding in cirrhosisISRCTN16334693Individual sponsor (Germany)186
进行中（未招募）
不适用
Covered Transjugular Intrahepatic Portosystemic Stent Shunt versus Optimized medical Treatment for the Secondary Prevention of Variceal Bleeding in Cirrhosisliver cirrhosisesophageal (variceal) bleedingEUCTR2005-003557-27-DEDean of the Medical Faculty (University of Bonn)